• Activity INFORMATION

  Overview

  Prevention of HIV transmission is a national goal for the US. In patients looking to prevent acquisition of HIV, the use of preexposure prophylaxis has proven safe and effective, as long as it is taken as prescribed. In 2017, 38,739 patients managed to acquire HIV (an increase from 2016). Pharmacists have the potential to be at the forefront of preventing HIV and providing patients with tools on how to limit their risk. This session explores the intricacies of PrEP for the prevention of HIV while meeting the Florida-specific requirements for professional education programming on the topics of HIV and AIDS.
  

  Handouts

  • Homestudy PDF :   22036H02.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Cite current Florida law on AIDS and its impact on testing, confidentiality of test results, and treatment of patients, including the offering of HIV testing to pregnant women and partner notification issues

  Recognize the modes of transmission of HIV, including transmission from a healthcare worker to a patient and the patient to the healthcare worker

  Recognize appropriate infection control procedures, including universal precautions

  Recognize the safety, monitoring parameters, and efficacy of PrEP in at-risk populations based on the epidemiology and related infections

  Select appropriate patient education (safety, adherence, dosing, administration, potential drug-drug interactions) for the appropriate use of PrEP

  Identify appropriate candidates for initiation of preexposure prophylaxis (PrEP)

  Pharmacy Technician

  Recognize appropriate infection control procedures, including universal precautions

  Recognize appropriate candidates for initiation of PrEP

  Recognize the modes of transmission of HIV, including transmission from a healthcare worker to a patient and the patient to the healthcare worker

  Cite current Florida law on AIDS and its impact on testing, confidentiality of test results, and treatment of patients, including the offering of HIV testing to pregnant women and partner notification issues

  Identify safety concerns PrEP in at-risk populations based on epidemiology and related infections

  Nurse

  Recognize appropriate infection control procedures, including universal precautions

  Identify appropriate candidates for initiation of preexposure prophylaxis (PrEP)

  Recognize the modes of transmission of HIV, including transmission from a healthcare worker to a patient and the patient to the healthcare worker

  Cite current Florida law on AIDS and its impact on testing, confidentiality of test results, and treatment of patients, including the offering of HIV testing to pregnant women and partner notification issues

  Recognize the safety, monitoring parameters, and efficacy of PrEP in at-risk populations based on the epidemiology and related infections

  Select appropriate patient education (safety, adherence, dosing, administration, potential drug-drug interactions) for the appropriate use of PrEP

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-890139

  Universal Activity Number

  Pharmacist 0798-0000-22-036-H02-P
  Pharmacy Technician 0798-0000-22-036-H02-T
  Nurse 0798-0000-22-036-H02-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Melissa  Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, AAHIVP Clinical Associate Professor, University of Illinois at Chicago, College of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).